Results ADVOCATE study in NEJM


On February 18th 2021 the results of an important clinical study were published in the New England Journal of Medicine.   The trial was conducted from March 15, 2017, until November 1, 2019 (last trial visit).   In a phase 3 randomized trial (ADVOCATE) the avacopan product was compared with a tapering schedule of prednisone […]